Because patients with GH-PA have a higher incidence of diabetes, which is the most well-known indication for the use of metformin, we explored the potential effects of metformin on the growth and GH secretion of GH-PAs in vitro using GH3 cell line, primary tumor cells and in vivo using nude mice. This evidence concerns the gene GH1 and neoplasm.